IL-38 as an early predictor of the ischemic stroke prognosis.

Zare Rafie, Maryam; Esmaeilzadeh, Abdolreza; Ghoreishi, Abdolreza; Tahmasebi, Safa; Faghihzadeh, Elham; Elahi, Reza

Zare Rafie, Maryam; Esmaeilzadeh, Abdolreza; Ghoreishi, Abdolreza; Tahmasebi, Safa; Faghihzadeh, Elham; Elahi, Reza.

Afiliación

Zare Rafie M; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Esmaeilzadeh A; Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. Electronic address: a46reza@zums.ac.ir.
Ghoreishi A; Stroke Research Group, Head of Stroke Care Unit, Department of Neurology, Vali-e-Asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Iran.
Tahmasebi S; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Faghihzadeh E; Department of Biostatistics and Epidemiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Elahi R; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

Cytokine ; 146: 155626, 2021 10.

Article en En | MEDLINE | ID: mdl-34157522

Asunto(s)

Isquemia Encefálica/sangre; Interleucinas/sangre; Accidente Cerebrovascular Isquémico/sangre; Anciano; Isquemia Encefálica/complicaciones; Femenino; Humanos; Accidente Cerebrovascular Isquémico/complicaciones; Masculino; Pronóstico; Daño por Reperfusión/sangre; Daño por Reperfusión/complicaciones

Palabras clave

Interleukin-38; Ischemic Stroke; Prognosis; tPA

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Isquemia Encefálica / Interleucinas / Accidente Cerebrovascular Isquémico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Cytokine Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google